TSHA-101 is an AAV9 viral vector carrying the HEXA and HEXB genes, delivered by intrathecal injection. It is being studied in infantile GM2 gangliosidosis, including Tay-Sachs and Sandhoff disease.
Summary written with AI from the sources listed at the end of this page.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.